NCT01728753View on ClinicalTrials.gov

T-705a Multicenter Study in Adults Subjects With Uncomplicated Influenza

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

550

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions
Influenza
Interventions
DRUG

Placebo

Placebo BID x 1 day, and Placebo BID x 4 days; Placebo TID x 1 day, and Placebo TID x 4 days

DRUG

Favipiravir

1200 mg TID on Day 1, then 600 mg TID on Days 2-5

DRUG

Favipiravir

2400 mg loading dose followed by 600 mg + 600 mg on Day 1, then 600 mg TID on Days 2-5

DRUG

Favipiravir

1800 mg BID on Day 1, then 800mg BID for Days 2 5

Trial Locations (1)

33143

Miami Research Associates, Miami

All Listed Sponsors
collaborator

United States Department of Defense

FED

lead

MDVI, LLC

INDUSTRY

NCT01728753 - T-705a Multicenter Study in Adults Subjects With Uncomplicated Influenza | Biotech Hunter | Biotech Hunter